对比水上运动和陆上运动对老年人平衡的影响:系统性审查和元分析
Ying Deng1, Zheng Tang1, Zhengting Yang1
1Sichuan University, West China Hospital, Chengdu, 610041, Sichuan, China.
概括
水中运动 (AE) 对改善老年人的平衡比陆地运动 (LE) 有更大的益处,特别是在Berg平衡量级和30秒的椅子站测试中. 这些发现表明,AE是提高这一群体平衡的优越选择.
科学领域:
- 老年学是指老年学的学科.
- 运动生理学 运动生理学
- 康复科学 康复科学 康复科学
背景情况:
- 平衡对于老年人的日常功能至关重要.
- 水上运动 (AE) 和陆上运动 (LE) 是平衡改善的常见方法.
- 之前对AE和LE进行平衡的研究已经产生了不一致的结果.
研究的目的:
- 为了比较水中运动 (AE) 与陆地运动 (LE) 对老年人平衡功能的影响.
- 综合来自随机对照试验对老年人平衡的运动干预措施的证据.
主要方法:
- 随机对照试验的系统审查和元分析.
- 从2003年1月到2023年6月,搜索了主要的电子数据库 (PubMed,科学网,Scopus,Embase).
- 使用物理治疗证据数据库 (PEDro) 尺度评估研究质量和使用RevMan 5.3.3合成数据.
主要成果:
- 包括29项研究,涉及1486名老年人 (平均年龄66.2岁).
- 在Berg平衡量级 (SMD=1.13) 和30秒椅站测试 (SMD=2.02) 上,AE显著改善了平衡.
- 在6分钟步行测试或Time Up and Go测试中,在AE和LE之间没有发现显著差异.
结论:
- 与陆地运动 (LE) 相比,水中运动 (AE) 在改善老年人平衡的具体措施方面表现出更高的益处.
- 个人的健康状况会影响AE和LE干预所观察到的益处.
- 在老年人群中,AE是一种有前途的干预措施,用于增强平衡功能.
相关概念视频
Drug Dosing: Geriatric Patients
402
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
402
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
387
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
387
Pharmacodynamics in Geriatric Patients: Effects of Age
378
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
378


